Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction

Abstract Plasma dipeptidyl-peptidase-4 activity (DPP4a) is inversely associated with left ventricular function in patients with heart failure (HF) or diabetes. However, the association between DPP4a and left ventricular function in ST-segment elevation myocardial infarction (STEMI) patients has not...

Full description

Bibliographic Details
Main Authors: Jing Wei Li, Yun Dai Chen, Yu Qi Liu, Jin Da Wang, Wei Ren Chen, Ying Qian Zhang, Qiang Ma
Format: Article
Language:English
Published: Nature Portfolio 2017-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-017-06514-3
_version_ 1818750777165873152
author Jing Wei Li
Yun Dai Chen
Yu Qi Liu
Jin Da Wang
Wei Ren Chen
Ying Qian Zhang
Qiang Ma
author_facet Jing Wei Li
Yun Dai Chen
Yu Qi Liu
Jin Da Wang
Wei Ren Chen
Ying Qian Zhang
Qiang Ma
author_sort Jing Wei Li
collection DOAJ
description Abstract Plasma dipeptidyl-peptidase-4 activity (DPP4a) is inversely associated with left ventricular function in patients with heart failure (HF) or diabetes. However, the association between DPP4a and left ventricular function in ST-segment elevation myocardial infarction (STEMI) patients has not been reported. We studied this association in 584 consecutive STEMI patients at a tertiary referral center from July 2014 to October 2015. DPP4a and plasma N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) levels were quantified by enzymatic assays. The median serum NT-proBNP levels were highest in patients of the lowest tertile (T1) of DPP4a compared with that of the highest tertile (T3) (p = 0.028). The STEMI patients in T1 exhibited lower left ventricular systolic function (T1 vs. T3: left ventricular ejection fraction (LVEF): 50.13 ± 9.12 vs. 52.85 ± 6.82%, p = 0.001). Multivariate logistic-regression analyses (adjusted for confounding variables) showed that a 1 U/L increase in DPP4a was associated with a decreased incidence of left ventricular systolic dysfunction (LVSD) (adjusted odds ratio: 0.90; 95% CI: 0.87–0.94; p < 0.01). In conclusion, low DPP4a is independently associated with LVSD in STEMI patients, which suggests that DPP4 may be involved in the mechanisms of LVSD in STEMI patients.
first_indexed 2024-12-18T04:25:04Z
format Article
id doaj.art-8986382ab998465e95377da0e4c9366a
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-18T04:25:04Z
publishDate 2017-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-8986382ab998465e95377da0e4c9366a2022-12-21T21:21:07ZengNature PortfolioScientific Reports2045-23222017-07-01711810.1038/s41598-017-06514-3Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarctionJing Wei Li0Yun Dai Chen1Yu Qi Liu2Jin Da Wang3Wei Ren Chen4Ying Qian Zhang5Qiang Ma6Department of Cardiology, PLA General HospitalDepartment of Cardiology, PLA General HospitalDepartment of Cardiology, PLA General HospitalDepartment of Cardiology, PLA General HospitalDepartment of Cardiology, PLA General HospitalDepartment of Cardiology, PLA General HospitalDepartment of Cardiology, PLA General HospitalAbstract Plasma dipeptidyl-peptidase-4 activity (DPP4a) is inversely associated with left ventricular function in patients with heart failure (HF) or diabetes. However, the association between DPP4a and left ventricular function in ST-segment elevation myocardial infarction (STEMI) patients has not been reported. We studied this association in 584 consecutive STEMI patients at a tertiary referral center from July 2014 to October 2015. DPP4a and plasma N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) levels were quantified by enzymatic assays. The median serum NT-proBNP levels were highest in patients of the lowest tertile (T1) of DPP4a compared with that of the highest tertile (T3) (p = 0.028). The STEMI patients in T1 exhibited lower left ventricular systolic function (T1 vs. T3: left ventricular ejection fraction (LVEF): 50.13 ± 9.12 vs. 52.85 ± 6.82%, p = 0.001). Multivariate logistic-regression analyses (adjusted for confounding variables) showed that a 1 U/L increase in DPP4a was associated with a decreased incidence of left ventricular systolic dysfunction (LVSD) (adjusted odds ratio: 0.90; 95% CI: 0.87–0.94; p < 0.01). In conclusion, low DPP4a is independently associated with LVSD in STEMI patients, which suggests that DPP4 may be involved in the mechanisms of LVSD in STEMI patients.https://doi.org/10.1038/s41598-017-06514-3
spellingShingle Jing Wei Li
Yun Dai Chen
Yu Qi Liu
Jin Da Wang
Wei Ren Chen
Ying Qian Zhang
Qiang Ma
Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction
Scientific Reports
title Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction
title_full Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction
title_fullStr Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction
title_full_unstemmed Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction
title_short Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction
title_sort plasma dipeptidyl peptidase 4 activity is associated with left ventricular systolic function in patients with st segment elevation myocardial infarction
url https://doi.org/10.1038/s41598-017-06514-3
work_keys_str_mv AT jingweili plasmadipeptidylpeptidase4activityisassociatedwithleftventricularsystolicfunctioninpatientswithstsegmentelevationmyocardialinfarction
AT yundaichen plasmadipeptidylpeptidase4activityisassociatedwithleftventricularsystolicfunctioninpatientswithstsegmentelevationmyocardialinfarction
AT yuqiliu plasmadipeptidylpeptidase4activityisassociatedwithleftventricularsystolicfunctioninpatientswithstsegmentelevationmyocardialinfarction
AT jindawang plasmadipeptidylpeptidase4activityisassociatedwithleftventricularsystolicfunctioninpatientswithstsegmentelevationmyocardialinfarction
AT weirenchen plasmadipeptidylpeptidase4activityisassociatedwithleftventricularsystolicfunctioninpatientswithstsegmentelevationmyocardialinfarction
AT yingqianzhang plasmadipeptidylpeptidase4activityisassociatedwithleftventricularsystolicfunctioninpatientswithstsegmentelevationmyocardialinfarction
AT qiangma plasmadipeptidylpeptidase4activityisassociatedwithleftventricularsystolicfunctioninpatientswithstsegmentelevationmyocardialinfarction